Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Prymula

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Human Vaccines & Immunotherapeutics|July 15, 2017
Influenza vaccination in the elderlyJan Smetana, Roman Chlibek, Jana Shaw, et al.
Vaccine|January 30, 2007
Kinetics of the immune response following pneumococcal PD conjugate vaccinationLode Schuerman, Roman Prymula, Viktor Chrobok, et al.
Vaccine|August 12, 2009
Prevention of otitis media: now a reality?Lode Schuerman, Dorota Borys, Bernard Hoet, et al.
Vaccine|June 13, 2017
Vaccination in newly arrived immigrants to the European UnionRoman Prymula, Jana Shaw, Roman Chlibek, et al.
Advances in Therapy|January 10, 2012
Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and TurkeyRoman Prymula, Gaye Usluer, Serdar Altinel, et al.
Human Vaccines|April 4, 2007
The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infantsRoman Prymula, Marie-Pierre David, Inge Lefevre, et al.
Vaccine|April 5, 2014
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trialRoman Prymula, Petr Pazdiora, Magali Traskine, et al.
BMC Public Health|February 5, 2025
Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based studyVojtech Kamenský, Lukáš Dostálek, Martin Rožánek, et al.
Vaccine|August 12, 2017
Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and SlovakiaIngrid Urbancikova, Roman Prymula, David Goldblatt, et al.
Vaccine|October 13, 2009
Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of ageRoman Prymula, Pavla Kriz, Eva Kaliskova, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Human Vaccines & Immunotherapeutics|July 15, 2017
Influenza vaccination in the elderlyJan Smetana, Roman Chlibek, Jana Shaw, et al.
Vaccine|January 30, 2007
Kinetics of the immune response following pneumococcal PD conjugate vaccinationLode Schuerman, Roman Prymula, Viktor Chrobok, et al.
Vaccine|August 12, 2009
Prevention of otitis media: now a reality?Lode Schuerman, Dorota Borys, Bernard Hoet, et al.
Vaccine|June 13, 2017
Vaccination in newly arrived immigrants to the European UnionRoman Prymula, Jana Shaw, Roman Chlibek, et al.
Advances in Therapy|January 10, 2012
Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and TurkeyRoman Prymula, Gaye Usluer, Serdar Altinel, et al.
Human Vaccines|April 4, 2007
The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infantsRoman Prymula, Marie-Pierre David, Inge Lefevre, et al.
Vaccine|April 5, 2014
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trialRoman Prymula, Petr Pazdiora, Magali Traskine, et al.
BMC Public Health|February 5, 2025
Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based studyVojtech Kamenský, Lukáš Dostálek, Martin Rožánek, et al.
Vaccine|August 12, 2017
Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and SlovakiaIngrid Urbancikova, Roman Prymula, David Goldblatt, et al.
Vaccine|October 13, 2009
Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of ageRoman Prymula, Pavla Kriz, Eva Kaliskova, et al.
Pageof 8